ReGen Establishes Branded Marketing Activities in Europe

May 27, 2005

ReGen Biologics, an orthopedic products company that develops, manufactures, and markets innovative tissue growth and repair products for U.S. and global markets, announced that it has established branded marketing and distribution of the patented ReGen Collagen Meniscus Implant (CMI) and other products in Europe. In March 2005, ReGen Biologics founded a wholly owned subsidiary in Switzerland, ReGen Biologics AG, with the intent to build a proprietary brand in Europe by marketing and distributing the CMI and other products in Europe directly and through a network of local market distributors.

()a href="http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050526005735&newsLang=en" target="_blank">Business Wire